PlainRecalls
FDA Drug Moderate Class II Ongoing

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.

Reported: February 21, 2024 Initiated: January 22, 2024 #D-0325-2024

Product Description

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.

Reason for Recall

Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.

Details

Units Affected
1,299 syringes
Distribution
MN
Location
Minneapolis, MN

Frequently Asked Questions

What product was recalled?
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.. Recalled by IntegraDose Compounding Services LLC. Units affected: 1,299 syringes.
Why was this product recalled?
Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 21, 2024. Severity: Moderate. Recall number: D-0325-2024.